MEI Pharma, Inc. (MEIP): $MEIP building a stairway to heaven :)

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	29
Posts	3135
Boards Moderated	0
Alias Born	01/14/2010

wplong89

Re: vantillian post# 1091

Monday, 04/11/2016 1:28:42 PM

Monday, April 11, 2016 1:28:42 PM

$MEIP building a stairway to heaven :)

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent MEIP News

Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:10:09 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:05:23 PM
MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position • Business Wire • 11/12/2024 09:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2024 08:05:08 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/19/2024 09:20:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 09:05:07 PM
MEI Pharma Reports Fiscal Year End 2024 Cash Position • Business Wire • 09/19/2024 08:01:00 PM
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives • Business Wire • 08/12/2024 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:05:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:05:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/22/2024 09:25:09 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/22/2024 08:06:33 PM
MEI Pharma to Consider Strategic Alternatives • Business Wire • 07/22/2024 12:30:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 08:00:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 05:00:22 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 08:00:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:02:15 PM
MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights • Business Wire • 05/09/2024 08:02:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:00:47 PM
MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344 • Business Wire • 04/11/2024 12:02:00 PM
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients • Business Wire • 04/11/2024 12:00:00 PM
MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum • Business Wire • 04/10/2024 12:00:00 PM
MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia • Business Wire • 03/26/2024 12:00:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/29/2024 05:15:45 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:00:17 PM

More MEIP News

InvestorsHub NewsWire

Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM

Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM

Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM

Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM

Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover